Yu Darvish diagnosed with mild elbow inflammation

1 Comment

Rangers right-hander Yu Darvish was placed on the disabled list yesterday with right elbow inflammation, but the good news is that it’s not considered serious.

According to Gerry Fraley of the Dallas Morning News, Darvish underwent tests today which showed that the inflammation is mild. Team physician Keith Meister said there’s no indication that this is a long-term issue which will require surgery, but Darvish won’t be cleared to resume throwing until the soreness subsides. And so, it’s unclear whether he will pitch again this season, but there’s no real sense of urgency since the Rangers have the worst record in the majors.

“I want to go out there and compete, but I also think about the long-term situation,” Darvish said. “I don’t want to go out there and risk my future. I don’t want my elbow to be aggravated.”

Darvish has been on the DL in each of his three seasons with the Rangers. A Major League Baseball season is harder on pitchers than what he experienced in Japan Darvish said.

“It’s evident because of so many injuries we have in Major League Baseball,” Darvish said.

Darvish, 27, has compiled a 3.06 ERA and 182/49 K/BB ratio in 144 1/3 innings this season. He’s owed $31 million over the next three seasons, a sum which has the potential to prove as a major bargain if he can remain healthy.

Mets sign reliever Anthony Swarzak

Getty Images
Leave a comment

Marc Carig of Newsday reports that the Mets have signed reliever Anthony Swarzak. It’s a two-year, $14 million deal, pending a physical.

Swarzak is an eight-year big league veteran who pitched for the White Sox and Brewers in 2017, posting a 2.33 ERA in 70 games. The righty struck out 10.6 batters per nine innings while walking 2.6. It was a really nice year and he’s a really nice pickup for the Mets, even if he is a fallback choice after they failed to sign Bryan Shaw.